Skip to main content

Ilina
C.
Odouard
,
MPH

Research Associate

Ilina Odouard, MPH ’23, focuses on influencing pharmaceutical policy changes that promote affordability, access, and health equity through regulatory and payment reform.

Contact Info

Research Interests

Prescription drugs, pharmaceutical policy, drug price negotiation, value-based payment, pharmaceutical innovation

Experiences & Accomplishments
Education
MPH
JHU Bloomberg School of Public Health
2023
BA
Barnard College of Columbia University
2018
Select Publications
  • Odouard, IC, Anderson, GF, Alexander, GC, Ballreich, J. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations. Journal of Managed Care & Specialty Pharmacy. 2024;30(3), 269–278. doi: https://doi.org/10.18553/jmcp.2023.23153

  • Socal MP, Odouard IC, Kharrazi H. Ownership and Interoperability Challenges of Alzheimer Monoclonal Antibody Registries. JAMA Neurol. 2024;81(2):109–110. doi:10.1001/jamaneurol.2023.4675

  • Odouard IC, Socal MP, Anderson GF. Role of Registries in Medicare Coverage of New Alzheimer Disease Drugs. JAMA. 2023;330(14):1331–1332. doi:10.1001/jama.2023.17131

  • DiStefano MJ, Levy JF, Odouard IC, Anderson GF. Estimated savings from using added therapeutic benefit and therapeutic reference pricing in United States Medicare drug price negotiations. Value in Health. 2023. doi: https://doi.org/10.1016/j.jval.2023.08.004.

Projects
My current projects focus on the clinical evidence, costs, and value-based payment models for gene and RNA therapies, pharmaceutical innovation, and coverage of genetic tests associated with targeted cancer therapies.